Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)

This indicator reflects the proportion of pregnant women diagnosed with HIV who are administered antiretroviral treatment aimed at preventing the transmission of the virus to their infants during childbirth and breastfeeding. High coverage rates signify effective healthcare systems and access to vital medications, which can dramatically reduce the risk of mother-to-child transmission (MTCT), a critical factor in improving maternal and infant health outcomes. Monitoring this metric not only highlights the success of public health initiatives but also underscores the need for ongoing support and education for both expectant mothers and healthcare providers. Emphasizing comprehensive and accessible PMTCT services ultimately fosters healthier futures for both mothers and their children. Source: